University of Pennsylvania
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1740-11-14
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.upenn.edu
Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone)
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2000-11-09
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 165
- Registration Number
- NCT00006489
- Locations
- 🇺🇸
Center for Anxiety, University of Pennsylvania, Philadelphia, Pennsylvania, United States
Parity and Serum Lipids in White and Hispanic Women
Completed
- Conditions
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- University of Pennsylvania
- Registration Number
- NCT00005405
SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea
Completed
- Conditions
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- University of Pennsylvania
- Registration Number
- NCT00005511
Sertraline for Alcohol Dependence and Depression
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2000-02-07
- Last Posted Date
- 2015-10-06
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 171
- Registration Number
- NCT00004554
- Locations
- 🇺🇸
Treatment Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States
Preliminary Testing of New Treatment for Chronic Leg Wounds
- First Posted Date
- 2000-01-19
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 24
- Registration Number
- NCT00000431
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Treatment of Obsessive-Compulsive Disorder (OCD) in Children
Phase 3
Completed
- Conditions
- First Posted Date
- 1999-11-03
- Last Posted Date
- 2016-08-22
- Lead Sponsor
- University of Pennsylvania
- Registration Number
- NCT00000384
- Locations
- 🇺🇸
Duke Univ. Med. Ctr., Durham, North Carolina, United States
🇺🇸Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
Cognitive and Drug Therapy for Drug-Resistant Depression
Not Applicable
Completed
- Conditions
- First Posted Date
- 1999-11-03
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- University of Pennsylvania
- Registration Number
- NCT00000376
Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults With Partial Ornithine Transcarbamylase Deficiency
Phase 1
Terminated
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 21
- Registration Number
- NCT00004498
Piracetam for Treatment of Cocaine Addiction - 3
Phase 1
Completed
- Conditions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2015-10-06
- Lead Sponsor
- University of Pennsylvania
- Registration Number
- NCT00000198
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
Phase 1
Withdrawn
- Conditions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- University of Pennsylvania
- Registration Number
- NCT00000199
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
© Copyright 2024. All Rights Reserved by MedPath